Prime Therapeutics unveils its Diversity, Equity and Inclusion Transparency Report

Second annual report gives a transparent overview of Prime’s organizational makeup, highlights milestones along its journey

May 4, 2023

Prime Therapeutics (Prime) released its second annual Diversity, Equity And Inclusion (DEI) Transparency Report which provides a transparent look into its corporate culture through a DEI-focused lens. This year’s report provides an overview of Prime’s progress since 2018 and examines year-over-year improvement, acknowledging the enduring journey ahead.

Releasing this report aligns with Prime’s vision for diversity and inclusion efforts to be seen, heard and felt throughout the company, becoming part of its organizational DNA.

The report provides a clear look at Prime’s organizational makeup and highlights the milestones of the Prime Together Foundation, Diversity & Inclusion Council and employee resource groups. Additionally, it gives insight into various initiatives such as health and pay equity and Prime’s Beyond the Yellow Ribbon (BTYR) designation, awarded for its support of military employees and their families.

Erin Feigal

Specific accomplishments include:

  • Scoring 90 out of 100 on the Disability Equality Index®
  • Signing the “CEOs are IN” commitment for disability inclusion
  • Publishing gender transition resources for leaders and transitioning employees
  • Expanding DEI-related learning and training experiences for employees
  • Updating copy style guidelines to be more inclusive

“At Prime, we believe in the importance of transparency. We are proud of the progress we have made over the last few years with diversity, equity and inclusion,” said Erin Feigal, senior vice president and chief human resources officer for Prime. “While there is still work to be done, we are committed to driving progress to ensure we make positive strides on our DEI journey.”

DEI Transparency Report Highlights

Forty-two percent of Prime’s workforce identifies as one of the following: American Indian or Alaska Native (0.9%), Asian (13.3%), Black or African American (12.5%), Hispanic or Latino (6.8%), Native Hawaiian or Other Pacific Islander (0.4%), Two or More Races (3%), or Other (5.1%); 57.9% identify as White.

Prime saw an increase from 2021 in the following categories:

  • 7% increase (162% growth) in Black or African American leadership representation
  • 2% increase (134% growth) in Two or More Races representation
  • 6% increase (50% growth) in Asian leadership representation
  • 1% increase (49% growth) in Black or African American representation
  • 9% increase (5% growth) in female leadership

Review in detail the 2022 DEI Transparency Report to better understand Prime’s progress and ongoing DEI initiatives.

Related news


April 5, 2024

LISTEN NOW: Revolutionizing Healthcare: Prime & Capital Rx’s Game-Changing Alliance – Pharmacy Friends podcast

In this special episode of the Pharmacy Friends podcast, the CEOs of Prime Therapeutics, Mostafa Kamal, and Capital Rx, AJ Loiacono, join Michael Passanante, SVP of Marketing & Communications at Capital Rx, to share the story behind the strategic alliance between the organizations and their vision to reimagine pharmacy.


March 26, 2024

Announcing the new issue of Prime’s managed care report, featuring the latest trends and updates in medical and pharmacy benefits

Prime Therapeutics/Magellan Rx (Prime/MRx) today launched the spring edition of Magellan Rx Report…


March 19, 2024

Healthcare Businesswomen’s Association names Simone Ndujiuba and Jacki Shugart among 2024 Rising Stars 

Prime Therapeutics/Magellan Rx’s Director of Clinical Strategy and Innovation Simone Ndujiuba and Senior Program Manager Jacki Shugart honored for female leadership in the health care industry